Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
Go back to Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities| (NASDAQ: KALA) | Delayed: 3.12 -0.42 (11.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.54 | 52 Week High | $ | |||
| Open | $3.36 | 52 Week Low | $ | |||
| Day High | $3.54 | P/E | N/A | |||
| Day Low | $3.11 | EPS | $ | |||
| Volume | 67,632 | |||||
| (NASDAQ: KALA) | Delayed: 3.12 -0.42 (11.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.54 | 52 Week High | $ | |||
| Open | $3.36 | 52 Week Low | $ | |||
| Day High | $3.54 | P/E | N/A | |||
| Day Low | $3.11 | EPS | $ | |||
| Volume | 67,632 | |||||

